Statin drugs to reduce breast cancer recurrence and mortality

Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for the treatment of high cholesterol and atherosclerotic coronary artery disease and are widely used. This has engendered studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Beckwitt, Colin H., Brufsky, Adam, Oltvai, Zoltán N., Wells, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247616/
https://www.ncbi.nlm.nih.gov/pubmed/30458856
http://dx.doi.org/10.1186/s13058-018-1066-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247616/
https://www.ncbi.nlm.nih.gov/pubmed/30458856
http://dx.doi.org/10.1186/s13058-018-1066-z

Ejemplares similares